DLA Piper has advised the global Israeli food company ICL on the acquisition of milk protein specialist Prolactal.  In the course of the transaction ICL acquired Prolactal and its German subsidiary Rovita GmbH. Prolactal is a leading European manufacturer of milk proteins and other ingredients for the food and beverage industry based in the Hartberg, Austria and in Engelsberg, Germany. The contracts have already been signed, the approval of the Austrian and German antitrust authorities is expected within the current quarter.

Prolactal has been a privately held company with an annual turnover of approximately EUR 100 million (2014). The company manufactures and distributes a wide range of functional milk proteins to stabilise and improve the nutritional quality of drinks and food. ICL is a global producer of agricultural products, processed foods and specially developed technical materials based in Tel Aviv.

"This transaction is another great example of our cross-border M&A expertise", says Christoph Mager, partner and head of the corporate group in DLA Piper's Vienna office. "We are pleased to have contributed to the successful implementation of this deal with our experienced and efficient team."

The Vienna team led by Christoph Mager included Johanna Höltl, senior lead lawyer und Suzy Park, senior associate (corporate), Alexander Taiyo Scheuwimmer, senior associate und Stefan Würrer, senior associate (finance), Stefan Panic, associate (IPT), Christian Stuppnig, senior associate (employment) and Florian Schuhmacher, senior consultant (competition). The German team was headed by Kirsten Girnth, partner und Birka Stroschein, senior associate (both Frankfurt).